In addition, GLP-1 agents have also been shown to have several cardiovascular benefits with blood pressure control, atherosclerosis, heart failure, and cardiovascular disease outcomes
This condition, known as hypoglycemia, can cause dizziness, confusion, and fainting
First developed to treat type 2 diabetes, these medicines are now delivering breakthrough results in obesity care
Propionyl-L-carnitine (200 mg/kg, p.o., drinking water) increases NO synthesis by enhancing eNOS expression in spontaneously hypertensive rats [8]
NRAS activating mutations are prevalent in CM at 29% (79), while the mutation frequency in MM is only 18% ( NRAS missense mutations occur at codon 61 in CM, compared to 54% for MM
[DOI] [PMC free article] [PubMed] [Google Scholar] 76.Deigendesch N., Sironi L., Kutza M., Wischnewski S., Fuchs V., Hench J., Frank A., Nienhold R., Mertz K.D., Cathomas G., Matter M.S., Siegemund M., Tolnay M., Schirmer L., Prbstel A.K., Tzankov A., Frank S